logo ART Corporation
Braquiterapia
 
Braquiterapia HDR/LDR
HDR afterloading

Brachytherapy is a form of radiotherapy in which cancer is treated by irradiation from a short distance. The radioactive source is placed directly inside or close to the site of the tumour. This reduces the risk of damaging the surrounding healthy tissue, while providing a very high dose of localised radiation to the tumour cells. 
HDR (high dose rate) brachytherapy is conducted with a so-called HDR afterloader, also known as a Remote Afterloading System (RAL).
With the help of applicators and catheters, the very small radiation source is driven from a shielded safe – located inside the afterloader – directly into or next to the tumour. A computerised treatmentplanning program calculates precisely how long the source has to stay and radiate at the so-called dwell positions before being driven back into the safe. 
HDR brachytherapy can often be performed on an out-patient basis. Additionally, it is conducted in only a few fractions. This noticeably increases the patient’s quality of life.

Eckert & Ziegler BEBIG manufactures two lines of HDR afterloaders: MultiSource® and GyneSource®.

Both systems are mostly used to treat gynaecological cancers (cervix, endometrium), but also tumours of the prostate, breast, oesophagus, lung and bronchus, as well as the lip and oral cavity. 

Apart from the complete product portfolio for the Afterloading, Eckert & Ziegler BEBIGprovides full installation of the device onsite, technical service, as well as a professional training for the clinic personnel. 

Accusource 1000

MultiSource®

MultiSource® is an HDR afterloader designed for the entire range of HDR brachytherapy applications. The 40 Channel Support and the Channel Coding, as well as other features, allow the performance of even complex implants, providing optimal treatment safety.

With MultiSource®, the customer has the possibility to choose either a well-proven Ir-192 source or a unique, particularly cost-effective Co-60 source.

The integrated In-Vivo Dosimetry System of the MultiSource® afterloader saves space and makes handling more comfortable.

HDR brachytherapy can be conducted with a large variety of HDR applicators, catheters, needles and templates, all available at Eckert & Ziegler BEBIG.

An innovative and user friendly treatment planning system, HDRplus™ completes the HDR afterloading setup.

download Descargar ficha técnica
Accusource 1000

HDR Applicators

Eckert & Ziegler BEBIG offers a whole range of versatile applicators for intraluminal, interstitial, intracavitary and intra-operative treatments, as well as surface mould treatments.

Ver catálogo >>
Accusource 1000

HDRplus™

Full support of HDR planning
The software HDRplus™ delivers an optimised treatment plan and makes the process especially fast, flexible and precise.

download Descargar ficha técnica
Accusource 1000

Ir-192 Wire Source

Thin and flexible
Ir-192 wire sources are designed for manual afterloading. The main applications are the treatment of head and neck, breast, anal and gynaecological cancers by interstitial or intracavitary brachytherapy.

download Descargar ficha técnica
^ subir
Seeds

Eckert & Ziegler BEBIG manufactures small, permanent, radioactive implants so called seeds, which are used in LDR brachytherapy, mainly in the treatment of localised prostate cancer. The seeds take the form of little capsules containing a minuscule quantity of a radioactive isotope, I-125 (Iodine-125). They are implanted into the prostate, where they remain permanently and destroy the cancer cells. Permanent LDR brachytherapy with small radioactive sources is highly effective, especially in early stages of prostate cancer and causes relatively low side effects in comparison to alternative treatment options.

They are offered in different configurations: stranded (IsoCord®, IsoStrand®) seeds.

In addition to radioactive implants, Eckert & Ziegler BEBIG also provides full installation to hospitals, including treatment planning software (such as PSID), ultrasound scanners and a complete range of accessories, as well as professional training.

Accusource 1000

IsoCord®

IsoCord® is a seed chain with max. 75 seeds delivered in a safe and convenient magazine, which guarantees optimal radiation protection. During the whole process of loading the needles, the user is protected by integrated radiation shielding. IsoCord® provides excellent strand placement characteristics and outstanding visibility under X-ray and ultrasound. Moreover its special design enables optimal fixation in the prostate tissue considerably reducing the migration rate.
The unique strand cutting device IsoCord® Needle Loading Station allows safe and convenient cutting of the strand and direct loading of the implantation needles.
IsoCord® can be delivered with any IsoSeed® type.

download Descargar ficha técnica
Accusource 1000

IsoStrand®

IsoStrand® consists of 10 IsoSeed® spaced 1 cm apart. The unique design of the biodegradable spacers and the structure of the outer suture ensures excellent strand placement.

download Descargar ficha técnica
Accusource 1000

Treatment Planning Software

The new dimension in brachytherapy
PSID – Permanent Seed Implant Dosimetry is an innovative software for Prostate Brachytherapy with pre-, intraoperative and post planning.

download Descargar ficha técnica
^ subir
Ophthalmic

Eckert & Ziegler BEBIG offers a series of reliable products for temporary brachytherapy of eye cancers.

The company is the exclusive manufacturer of Ru-106 (Ruthenium-106) Ophthalmic Plaques, used to treat uveal melanoma and retinoblastoma. The product portfolio also includes the COMS Eye Applicators used together with the IsoSeeds® I-125 and the demonstration software Plaque Simulator.

Accusource 1000

Ru-106 Ophthalmic Plaques

Ru-106 Ophthalmic Plaques represent a unique brachytherapy source supplied by Eckert & Ziegler BEBIG for the treatment of uveal melanoma, retinoblastoma, melanoma of the iris and other applications. The plaques consist of a thin film of Ru-106, a beta emitter, encapsulated within pure silver sheets with a total thickness of only 1mm. Due to its half-life of 374 days, the Ru-106 Ophthalmic Plaques can be used a number of times within one year.

download Descargar ficha técnica
Accusource 1000

I-125 Ophthalmic Seeds

Ophthalmic Brachytherapy
IsoSeeds I-125 are used for treatment of uveal melanomas, retinoblastomas and other special applications.

download Descargar ficha técnica
Accusource 1000

COMS Eye Applicators

COMS Eye Applicators are used to treat intraocular tumours like uveal melanoma or retinoblastoma with I-125 Ophthalmic Seeds (IsoSeed® I25.S16). They consist of gold plaque shells and silicon inserts with an optimised slot pattern to place the seeds. COMS Eye Applicators are available in 5 different sizes.

download Descargar ficha técnica
Accusource 1000

Plaque Simulator

Plaque Simulator is an intelligent tool for simulating ophthalmic plaque therapy.

download Descargar ficha técnica
^ subir
 
Síganos